Guangxi Yunbo Health Technology Co., Ltd. wins first prize for growth enterprises at Qinzhou Science and Technology Entrepreneurship Competition
From July 30 to 31, the Qinzhou Session of the 13th China Innovation and Entrepreneurship Competition in Guangxi and the finals of the 11th Qinzhou Science and Technology Entrepreneurship Competition were held at Qinzhou High-tech Industry Service Center (Innovation Building). After two days of intense competition, Guangxi Yunbo Health Technology Co., Ltd., a subsidiary of the China-Malaysia Investment Holding Group, distinguished itself among numerous contenders by winning the first prize for growth enterprises. This victory enables the company to represent Qinzhou to participate in the semi-finals of the 13th China Innovation and Entrepreneurship Competition in Guangxi, with an opportunity to qualify for the competition at the national level.
First Prize for Growth Enterprises
“Research and Production of High-Strength Straight-Pressing Calcium Phosphate Granules” Project
The award-winning project, "Research and Production of High-Strength Straight-Pressing Calcium Phosphate Granules" developed by Guangxi Yunbo Health Technology Co., Ltd., employs proprietary controlled-speed crystallization technology to produce high-strength straight-pressing calcium phosphate granules, primarily intended for straight-pressing tablet production. In comparison to domestic competitors whose tablets typically produced with the compression strength of around 60 N, the calcium phosphate granules from this project exceed 90 N in compression strength. These tablets are characterized by excellent compressibility, high strength, finer average size, and uniform granules that easily disperse and suspend during use, offering a smoother taste and meeting the production needs of health and pharmaceutical companies.
This project garnered unanimous recognition in the competition, triumphing among 50 shortlisted projects.
Further Reading
Guangxi Yunbo Health Technology Co., Ltd. is a food additive manufacturing enterprise under the China-Malaysia Investment Holding Group. The company is dedicated to the integrated development of research, production, sales, and services related to calcium, magnesium, zinc, and compounded products. Currently, it operates three granulation production lines and three compounded production lines with an annual capacity of 5,000 tons. The company also has its own quality control (QC) laboratory, microbiology laboratory, and application laboratory. Its products are primarily exported to Europe, America, Australia, and other regions, mainly serving world-renowned companies such as Kraft, Nestlé, and Swisse.